New Cannabis IPOs – Clover Leaf Prices $125M, Silver Spike Prices $150M
Maxim Group Gives Buy Rating To 10 Psychedelic Stocks: Compass, MindMed, Cybin, Field Trip And More
New Cannabis IPOs – Clover Leaf Prices $125M, Silver Spike Prices $150M
Maxim Group Gives Buy Rating To 10 Psychedelic Stocks: Compass, MindMed, Cybin, Field Trip And More
Small-Cap Biotech Execs On Latest Advancements, Post-Pandemic Return To Fundamentals
Maxim Group Is Bullish About Biotricity Generating Over 100% Revenue Growth
Maxim Group Recent News
New Bear Takes A Bite Out Of Apple: Maxim Downgrades Stock To Sell
What's Behind TrovaGene's Volatile Ride?
Maxim Group Says Chipotle Has 'Enviable Position' Among Restaurant Stocks
Maxim Has An Appetite For Potbelly
A Dunkin' By Any Other Name: Maxim Raises Stock's Price Target
Maxim Projects Nearly 200% Upside Potential For Overstock, Names Blockchain, Retail As Drivers
Maxim: Habit Restaurants No Longer A Buy, Consider Del Taco Instead
Cracker Barrel Is Undervalued, Maxim Says In Upgrade
After 44% Run, Domino's Pizza Hit With A Downgrade On Valuation
Maxim Explains Viking Therapeutics' Sympathy Move With Madrigal
HP's Q2 Print, 3-D Printing Business Trigger Maxim Upgrade
Maxim Group: Apple's Long-Term Services Business 'Not Attractive Enough' For Bullish Rating
Zoe's Kitchen's Downgraded By Maxim After Tough Q1; Growth Story 'Broken For Now'
Omeros Elevated By Medicare Reimbursement And OMS721 Progress, Says Maxim
Aramchol's Failed Past Isn't Its Future; Galmed Gets An Upgrade
A Look At What MoviePass Has Accomplished In 6 Months
Analyst Confident In Helios And Matheson Thanks To MoviePass
Dunkin' Brands Is 2018's First Go-Private Rumor; Shares Benefit
Maxim Highlights Manhattan Bridge Capital, A Niche REIT With A Rising Dividend
Can NXT-ID's Crypto Platform Lead More Merchants To Accept Digital Currency? Maxim Weighs In
NXT-ID Rallies After Announcing Cryptocurrency Retail Payment Platform
Analyst: As The Food Sector Consolidates, Hain Celestial Could Be Attractive M&A Target
Analyst Doubts Bluebird Bio Shares — Up 200% In 2017 — Can Fly Much Higher